妊娠期SARS-CoV-2感染孕妇的母婴结局
这项跨国回顾性队列研究纳入22个国家72个中心的388例实验室确诊SARS-CoV-2感染单胎妊娠孕妇,复合不良母体结局发生率为12.1%,ICU入住率11.1%,机械通气率9.3%,死亡率0.8%;266例已分娩者中早产率26.3%,围产期死亡率4.1%,仅1例新生儿SARS-CoV-2检测阳性。
要点
- 孕妇SARS-CoV-2感染母体死亡率为0.8%,ICU入住率为11.1%。
- 已分娩者中早产(<37周)率为26.3%,围产期死亡率为4.1%。
- 垂直传播风险似乎可忽略,仅1例新生儿RT-PCR阳性。
诊断标准与关键数值
- 确诊SARS-CoV-2感染定义为鼻咽拭子标本实时RT-PCR检测阳性。
- 主要结局为母体死亡和疾病的复合指标,包括入住ICU、使用机械通气和死亡。
- 复合不良母体结局发生于47/388例(12.1%);43例(11.1%)入住ICU,36例(9.3%)需要机械通气,3例(0.8%)死亡。
- 266例已分娩者中,早产(<37周)率为26.3%(70/266);围产期死亡率为4.1%(11/266)。
- 251例活产婴儿中,69/251例(27.5%)入住新生儿ICU,5例(2.0%)新生儿死亡;仅1例(1/251,0.4%)新生儿SARS-CoV-2 RT-PCR阳性,其母亲在孕晚期检测阳性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the maternal and perinatal outcomes of pregnancies affected by SARS-CoV-2 infection.
METHODS: This was a multinational retrospective cohort study including women with a singleton pregnancy and laboratory-confirmed SARS-CoV-2 infection, conducted in 72 centers in 22 different countries in Europe, the USA, South America, Asia and Australia, between 1 February 2020 and 30 April 2020. Confirmed SARS-CoV-2 infection was defined as a positive result on real-time reverse-transcription polymerase chain reaction (RT-PCR) assay of nasopharyngeal swab specimens. The primary outcome was a composite measure of maternal mortality and morbidity, including admission to the intensive care unit (ICU), use of mechanical ventilation and death.
RESULTS: In total, 388 women with a singleton pregnancy tested positive for SARS-CoV-2 on RT-PCR of a nasopharyngeal swab and were included in the study. Composite adverse maternal outcome was observed in 47/388 (12.1%) women; 43 (11.1%) women were admitted to the ICU, 36 (9.3%) required mechanical ventilation and three (0.8%) died. Of the 388 women included in the study, 122 (31.4%) were still pregnant at the time of data analysis. Among the other 266 women, six (19.4% of the 31 women with first-trimester infection) had miscarriage, three (1.1%) had termination of pregnancy, six (2.3%) had stillbirth and 251 (94.4%) delivered a liveborn infant. The rate of preterm birth before 37 weeks' gestation was 26.3% (70/266). Of the 251 liveborn infants, 69/251 (27.5%) were admitted to the neonatal ICU, and there were five (2.0%) neonatal deaths. The overall rate of perinatal death was 4.1% (11/266). Only one (1/251, 0.4%) infant, born to a mother who tested positive during the third trimester, was found to be positive for SARS-CoV-2 on RT-PCR.
CONCLUSIONS: SARS-CoV-2 infection in pregnant women is associated with a 0.8% rate of maternal mortality, but an 11.1% rate of admission to the ICU. The risk of vertical transmission seems to be negligible. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection. Ultrasound Obstet Gynecol. 2021. PMID: 32926494. doi:10.1002/uog.23107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。